Pharm-Olam.co.uk is a multi-national Contract Research Organization (CRO)
About Pharm-Olam.co.uk
Pharm-Olam International started operations in 1994 with the premise of delivering cost-effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. Pharm-Olam International (POI) is a contract research organization based in Houston, Texas with offices in over 20 countries across the world, conducting studies in over 40 countries. The company conducts Phase I through Phase IV studies, as well as clinical services, such as Data Management, Pharmacovigilance, Biostatistics, and Regulatory Services.
Pharm-Olam began as a private CRO focusing on emerging markets in Central and Eastern Europe. Since its inception over 14 years ago, POI has grown throughout Europe, Russia, Africa, Asia, Latin America and North America, with a Corporate HQ in Houston Texas, Clinical & Data Management division in Princeton New Jersey and a European HQ in Ascot UK. With 25 offices in 22 countries around the world, Pharm-Olam has one of the largest geographic presences among CROs, while combining the advantages of communication and relationship management in a small company culture, with global resources and experience. POI offers flexible full service trial solutions from Virtual Biotech to Preferred Providerships with corporate mainstream Pharma. Coupled with trouble shooting skills, refined from POI's busy ‘Rescue Trial’ work, the company can offer fast and reliable patient recruitment and insight.
